Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization
- Haematologica. 2017 May;102(5):e170-e174. doi: 10.3324/haematol.2016.161570.
Affiliations
- 1. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
- 2. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany.
- 3. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 4. Institute for Pharmaceutical and Medicinal Chemistry, Department of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Germany.
- 5. Department of Hematology, Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany.
- 6. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany [email protected].
- 7. Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich, Germany.
PMID: 28154087
DOI: 10.3324/haematol.2016.161570
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-